Pharmacokinetic and pharmacodynamic properties of eptifabatide in healthy subjects receiving unfractionated heparin or the low-molecular-weight heparin enoxaparin

Author： Gretler D.D.  

Publisher： Elsevier

ISSN： 0149-2918

Source： Clinical Therapeutics, Vol.25, Iss.10, 2003-10, pp. : 2564-2574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis

By Deepa P.R.   Varalakshmi P.  

Clinica Chimica Acta, Vol. 339, Iss. 1, 2004-01 ,pp. : 105-115

Elsevier

Access to resources Recommend Favorite

Use of a Low-concentration Heparin Solution to Extend the Life of Central Venous Catheters in African Green Monkeys (Chlorocebus aethiops)

By Gamble Christopher S   Jacobsen Kenneth O   Leffel Elizabeth K   Pitt M M Louise  

Journal of the American Association for Laboratory Animal Science, Vol. 46, Iss. 3, 2007-05 ,pp. : 58-60

American Association for Laboratory Animal Science

Access to resources Recommend Favorite

Subcutaneous hematomas from prophylactic heparin use

By  

Clinical Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : 226-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Profiles of Rapid-Acting Artemisinins in the Antimalarial Therapy

By  

Current Drug Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 210-223

Bentham Science Publishers

Access to resources Recommend Favorite

Heparin-Induced Thrombocytopenia: Recommendations for Optimal Use of Recombinant Hirudin

By Lubenow N.   Greinacher A.  

BioDrugs, Vol. 14, Iss. 2, 2000-08 ,pp. : 109-125

Adis International

Access to resources Recommend Favorite